This website is intended for healthcare professionals only

Trending Topic

31 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Ventricular fibrillation (VF) is characterized by rapid (>300 beats a per minute), irregular electrical activation with variable electrocardiographic waveforms that prevents coordinated myocardial contraction, resulting in immediate loss of cardiac output.1 It most commonly occurs in the context of coronary artery disease.2,3 Resuscitation efforts are critically time-dependent: with each minute of untreated VF, the survival rate declines […]

Atherosclerosis

An Introduction to Atherosclerosis

Supported by:
US ATHEROSCLEROSIS PARTNER
Mark CompleteCompleted
BookmarkBookmarked

touchCARDIO Future Leaders 2026 Following the successful introduction last year of our touchCARDIO Future Leaders, we are delighted to announce that nominations are now open for the 2026 edition. This initiative celebrates the next generation of pioneers in cardiology, those whose passion, ...

Coverage from: EuroPCR Highlights

New late-breaking data presented on Day 3 of EuroPCR 2026 highlighted evolving approaches to antiplatelet therapy, transcatheter treatment of pure aortic regurgitation and procedural optimization in bicuspid TAVR

Mark CompleteCompleted
BookmarkBookmarked

Europe loses 1.7 million lives each year to cardiovascular disease, a burden that costs billions and affects millions more. The Safe Hearts Plan sets out an ambitious shift toward prevention, earlier detection and recognition of lifelong genetic risk. As expectations rise, debate is already growing over whether the strategy can translate bold goals into measurable improvements in care and outcomes across the EU.

4 mins
Sponsored Content
touchDATA POINT
For HCPs in: Saudi Arabia

This video highlights the efficacy and safety of lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HoFH) in the Phase III APH-19 trial.

Mark CompleteCompleted
BookmarkBookmarked

A first-of-its-kind CAR Treg therapy has shown plaque-reducing effects in a preclinical model of atherosclerosis, signalling a potential shift toward targeted immunomodulation in cardiovascular disease. Could OxLDL-directed Tregs become the next major advance in cardio-immunotherapy?

Mark CompleteCompleted
BookmarkBookmarked
Coverage from: ESC Highlights

The ESC Congress 2025 congress was an important meeting for clinical practice guidance in cardiology, with several major societies releasing long-awaited updates. As always, clinical practice guidelines remain central to cardiology, ensuring that the latest trial data and real-world evidence are rapidly translated into consistent, evidence-based patient care. This year’s congress saw the unveiling of important new documents across prevention, acute care and long-term management, equipping cardiologists with refined decision pathways, updated risk-stratification tools and clearer benchmarks to optimise patient outcomes.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

S3E1_What impact does sleep have on physicians and their patients? We all know sleep is important, but what happens when physicians don’t get enough? In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from ...

Mark CompleteCompleted
BookmarkBookmarked

In this Q&A, Dr Kheirkhah shares how her winding academic journey led her to a passion for atherosclerosis, the impact of collaborative mentorship, and her excitement for how big data, multi-omics and machine learning are reshaping cardiovascular risk prediction and disease prevention.

Mark CompleteCompleted
BookmarkBookmarked

The touchCARDIO journal Heart International has once again seen an increase in its Journal Impact Factor (JIF), rising from 1.9 in 2024 to 2.3 in 2025.

Mark CompleteCompleted
BookmarkBookmarked

This August, Boston will host one of the most influential gatherings in cardiovascular medicine as the American Society for Preventive Cardiology (ASPC) convenes its 2025 Congress on Cardiovascular Disease Prevention. Set for 1–3 August 2025 at the Omni Boston Hotel at the Seaport, Boston, MA, USA, the meeting will bring together global experts, showcase cutting-edge research, and feature more than 200 abstract posters.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Mark CompleteCompleted
BookmarkBookmarked

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

Abstract human heart shape with red cardio pulse line.
Mark CompleteCompleted
BookmarkBookmarked

Early-career cardiologists and researchers face a complex landscape: they must navigate the increasing clinical complexity of cardiovascular disease, stay abreast of rapid scientific developments and manage the pressures of clinical, academic and personal responsibilities. Recognising the need for greater support, ...

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

5 mins
Sponsored Content

In this engaging short animation, learn how cholesterol-lowering MTP inhibitors act to reduce cholesterol in people with homozygous familial hypercholesterolemia, and explore clinical data supporting their long-term hepatic safety.

Mark CompleteCompleted
BookmarkBookmarked

touchCARDIO is delighted to announce that Heart International has received an impressive new Impact Factor of 1.9 in the 2024 Journal Citation Reports (JCR). This achievement marks a notable increase from last year’s Impact Factor of 0.2 and highlights the journal’s growing influence in the cardiology field.

30 mins
touchIN CONVERSATION
Mark CompleteCompleted
BookmarkBookmarked

Watch cardiology experts discuss how the latest guidelines and treatments are applied to reduce ASCVD risk in patients with dyslipidemias

Mark CompleteCompleted
BookmarkBookmarked

Despite improved treatment of atherosclerotic cardiovascular disease, coronary artery disease (CAD) remains the leading cause of death and disability worldwide.1 Treatment of traditional risk factors, mainly low-density lipoprotein (LDL) cholesterol, is the foundation of atherosclerotic risk reduction. However, a considerable ...

Load More...
Close Popup